CD59 and type 2 diabetes mellitus: The research group of Prof J Halperin (Hematology lab Harvard) has demonstrated that by using a sensitive and specific enzyme-linked immunosorbent assay (ELISA) for glycated CD59 in blood, plasma glycated CD59 levels were significantly higher in individuals with T2D and independently predicted the response to the OGTT [11].